Cargando…
Improvements in obtaining and characterizing mouse cerebrospinal fluid(): Application to mouse hepatitis virus-induced encephalomyelitis
This report describes advances in techniques for analyzing cellular and humoral immune components in the cerebrospinal fluid (CSF) of the mouse that are applicable to other laboratory animals. CSF studies undertaken during experimental infection of mice with JHM strain virus (JHMV) of mouse hepatiti...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
1983
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172882/ https://www.ncbi.nlm.nih.gov/pubmed/6300186 http://dx.doi.org/10.1016/0165-5728(83)90017-6 |
_version_ | 1783524343813242880 |
---|---|
author | Fleming, John O. Ting, Jenny Y.P. Stohlman, Stephen A. Weiner, Leslie P. |
author_facet | Fleming, John O. Ting, Jenny Y.P. Stohlman, Stephen A. Weiner, Leslie P. |
author_sort | Fleming, John O. |
collection | PubMed |
description | This report describes advances in techniques for analyzing cellular and humoral immune components in the cerebrospinal fluid (CSF) of the mouse that are applicable to other laboratory animals. CSF studies undertaken during experimental infection of mice with JHM strain virus (JHMV) of mouse hepatitis virus are presented. A critical pitfall which can lead to erroneous or invalid results is contamination of the CSF by even minute quantities of blood. Means of avoiding this contamination are attention to anatomical reference points, the use of a micropipet, and prior intracardiac perfusion of animals with phosphate-buffered saline. Cells in the CSF were typed as either B, T, polymorphonuclear, or mononuclear cells by the combination of a microcytotoxicity assay and histologic stains. A radioimmunoassay (RIA) allowed quantification of antibodies to JHMV in the CSF and indicated the presence of intrathecal synthesis of antibody in chronically infected mice. The combined use of these sensitive methods makes possible CSF analysis in individual mice rather than in pooled groups. |
format | Online Article Text |
id | pubmed-7172882 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1983 |
publisher | Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71728822020-04-22 Improvements in obtaining and characterizing mouse cerebrospinal fluid(): Application to mouse hepatitis virus-induced encephalomyelitis Fleming, John O. Ting, Jenny Y.P. Stohlman, Stephen A. Weiner, Leslie P. J Neuroimmunol Article This report describes advances in techniques for analyzing cellular and humoral immune components in the cerebrospinal fluid (CSF) of the mouse that are applicable to other laboratory animals. CSF studies undertaken during experimental infection of mice with JHM strain virus (JHMV) of mouse hepatitis virus are presented. A critical pitfall which can lead to erroneous or invalid results is contamination of the CSF by even minute quantities of blood. Means of avoiding this contamination are attention to anatomical reference points, the use of a micropipet, and prior intracardiac perfusion of animals with phosphate-buffered saline. Cells in the CSF were typed as either B, T, polymorphonuclear, or mononuclear cells by the combination of a microcytotoxicity assay and histologic stains. A radioimmunoassay (RIA) allowed quantification of antibodies to JHMV in the CSF and indicated the presence of intrathecal synthesis of antibody in chronically infected mice. The combined use of these sensitive methods makes possible CSF analysis in individual mice rather than in pooled groups. Published by Elsevier B.V. 1983-04 2002-12-09 /pmc/articles/PMC7172882/ /pubmed/6300186 http://dx.doi.org/10.1016/0165-5728(83)90017-6 Text en Copyright © 1983 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Fleming, John O. Ting, Jenny Y.P. Stohlman, Stephen A. Weiner, Leslie P. Improvements in obtaining and characterizing mouse cerebrospinal fluid(): Application to mouse hepatitis virus-induced encephalomyelitis |
title | Improvements in obtaining and characterizing mouse cerebrospinal fluid(): Application to mouse hepatitis virus-induced encephalomyelitis |
title_full | Improvements in obtaining and characterizing mouse cerebrospinal fluid(): Application to mouse hepatitis virus-induced encephalomyelitis |
title_fullStr | Improvements in obtaining and characterizing mouse cerebrospinal fluid(): Application to mouse hepatitis virus-induced encephalomyelitis |
title_full_unstemmed | Improvements in obtaining and characterizing mouse cerebrospinal fluid(): Application to mouse hepatitis virus-induced encephalomyelitis |
title_short | Improvements in obtaining and characterizing mouse cerebrospinal fluid(): Application to mouse hepatitis virus-induced encephalomyelitis |
title_sort | improvements in obtaining and characterizing mouse cerebrospinal fluid(): application to mouse hepatitis virus-induced encephalomyelitis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172882/ https://www.ncbi.nlm.nih.gov/pubmed/6300186 http://dx.doi.org/10.1016/0165-5728(83)90017-6 |
work_keys_str_mv | AT flemingjohno improvementsinobtainingandcharacterizingmousecerebrospinalfluidapplicationtomousehepatitisvirusinducedencephalomyelitis AT tingjennyyp improvementsinobtainingandcharacterizingmousecerebrospinalfluidapplicationtomousehepatitisvirusinducedencephalomyelitis AT stohlmanstephena improvementsinobtainingandcharacterizingmousecerebrospinalfluidapplicationtomousehepatitisvirusinducedencephalomyelitis AT weinerlesliep improvementsinobtainingandcharacterizingmousecerebrospinalfluidapplicationtomousehepatitisvirusinducedencephalomyelitis |